| AR | EN
National Node of the BCH
Capacity Building Activities, Projects and Opportunities
Record information and status
Record ID
Date of creation
2002-11-04 04:06 UTC (dubravka.stepic@biodiv.org)
Date of last update
2010-01-25 10:03 UTC (intern.ross.carroll@cbd.int)
Date of publication
2010-01-25 10:03 UTC (intern.ross.carroll@cbd.int)

General information
Title of the initiative
Cameroon Capacity Building Project for the Implementation of National Biosafety Framework
Contact person
Ms. Mary Fosi Mbantenkhu
Technical Adviser No 1
Ministry of Environment and Nature Protection
Ministerial Building No. 2
6th floor
Phone:+237 222 94 80,+237 998 1568 (mobile)
Fax:+237 222 94 80 (tel fax)
Beneficiary country(ies)
  • Cameroon
  • CBD Regional Groups - Africa
Type of initiative
Main target group(s) / beneficiaries
  • Target group: Policy makers, regulators, decision makers, scientists and the public.
Start Date
Ending date
Donor(s) information
Government(s) sponsoring the initiative
  • Cameroon
Agency(ies) or Organization(s) implementing or sponsoring the initiative (Additional Information)
  • Organization: Ministry of the Environment and Forestry
  • Type of Organization: National government
  • Type of Organization: UN Agency
Budget information
GEF - $560300
In-kind contribution - $111100
Availability of funds for participants
Activity details
Description of the initiative
The Cameroon Capacity Building Project for the Implementation of National Biosafety Framework includes demand-driven activities that respond to the country's needs. Its main goal is to ensure safety in modern biotechnology in Cameroon and to maximize advantages of technology while reducing the risks emanating from LMOs.

The project aims at: developing institutional and human resource capacities (through the improvement of the existing infrastructure for safety in modern biotechnology, strengthening of national capacity of gene banks and quarantine facilities) to perform their functions and strengthening of the present capacity of the Biotechnology Centre for risk assessment activities.

Other objectives are: to carry out risk assessments and provide risk management training programmes; to facilitate the training of staff of key Government Biodiversity conservation institutions and NGOs; to ensure public awareness; and to create a Biosafety Portal linked to the SCBD/BCH and CHM.

National level activities
Development of national biosafety frameworks
Human-resources development
Information exchange & data management
Institutional strengthening
Public awareness, education and participation

Regional level activities
Centres of excellence and training.

Other source of funding
Objective and main expected outcomes or lesson learned
*To support the establishment of the regulatory and administrative biosafety management system in order to enable the safe research, development, use (including contained use), handling, transboundary movement, including transit, of genetically modified organisms that have an adverse effect on human/animal life, biodiversity and the environment in Cameroon and meet the obligations foreseen under the Cartagena Protocol.

*To build and, where appropriate, strengthen capacity at the scientific, legal and administrative levels of key government Ministries and other main stakeholders on how to implement biosafety regulations and therefore enable the safe research (on), use, commercialization and transfer of LMOs, identification and handling of LMOs.

*To expand or provide facilities for improving research and monitoring activities aimed at improving the assessment, management and monitoring of the risk associated to Living Modified Organisms (LMOs) as well as guaranteeing continuity of indigenous species. 

*To set up a Regional Center of Excellence for biosafety.

*To strengthen information sharing with relevant stakeholders, civil society, and community based organizations through networking, the Biosafety National Clearing House Portal and the involvement of NGOs.

*To enhance public awareness on biosafety issues, measures and procedures, disseminate information to the public, also using the traditional systems of communication.

The goal of the Project is to develop and strengthen the capacity of the Government of Cameroon in order to implement the Cartagena Protocol on Biosafety by: supporting the entry into force and implementation of national legislation, strengthening national biosafety facilities, training main stakeholders, establishing a good National Information System to be linked to the National Biosafety Clearing House and promoting public awareness.

Main outcomes
The following are the expected outcomes of the project:

1) Support provided to start the implementation of the regulatory/administrative biosafety management system according to the Bill on "Regulating Safety in Modern Biotechnology in Cameroon".

2)  Three national workshops carried out on biosafety legislation and procedures.

3) Training manual for policy makers, regulators and decision-makers on basic requirements for risk assessment and AIA procedure developed and disseminated.

4) NABA technical staff trained on procedures for implementing the National Biosafety Framework

5) Around 200 people (including representatives of NGOs, Community Based Organizations and Civil Society) trained in: legislative and administrative aspects related to national biosafety legislation, scientific experimentation, risk assessment and monitoring.

6) Staff of the Regional Center of Excellence for Biotechnology/Biosafety, once established, to be trained.

7) Three information management experts trained on-the-job in evaluation and dissemination of the BCH in order to facilitate the AIA process development.

8) Training programme on biosafety integrated into schools/university curricula.

9) Technical guidelines on risk assessment/monitoring developed and approved

10) Research facilities provided to IRAD, the Biotechnology Center and other University Centers to serve as centers for risk assessment, management and monitoring.

11) Equip laboratories, quarantine facilities and national gene banks to monitor/ensure the continuity of indigenous species of the nation's biological diversity.

12) A Regional Center of Excellence for Biotechnology/Biosafety established by strengthening the actual Biotechnology Center with laboratory equipment and other infrastructure needed for risk assessment/management/monitoring.

13) National Biosafety database system established and linked to the BCH.

14) Biosafety portal for Cameroon opened.
General thematic area(s)
  • Institutional capacity
  • Human resources capacity development and training
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
Additional Information
Additional Information
Cameroon is one of the most biodiversity-rich countries in Africa and one of the centres of genetic diversity in the sub-region. It is thus often qualified as "Africa in miniature". Cameroon considers promotion of safe research, development and application of biotechnology/biosafety as critical elements for biodiversity conservation and sustainable development.
Other relevant website address or attached documents